Back to Corient Private Wealth LP Corient Private Wealth LP

INTSINTS

2 quarters

Position history for Corient Private Wealth LPCorient Private Wealth LP's holdings in Intensity Therapeutics, Inc.

No. Corient Private Wealth exited its INTS (Intensity Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 100,000 shares worth $41,020. Corient Private Wealth first reported INTS in Q4 2025 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$41,020

Total Shares Change

-100,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$5.88
0
2025-Q4
New
100,000
—
$41,0200.0%$10.25
28

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used